Skip to main content
U.S. flag

An official website of the United States government

High‐fat diet protects the blood–brain barrier in an Alzheimer's disease mouse model

Bibliographic

Year of Publication:
2018
Contact PI Name:
Itzik Cooper
Contact PI Affiliation:
The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
Co-Authors:
S. Elhaik Goldman, D. Goez, D. Last, S. Naor, S. Liraz Zaltsman, I. Sharvit-Ginon, D. Atrakchi-Baranes, C. Shemesh, R. Twitto-Greenberg, S. Tsach, R. Lotan, A. Leikin-Frenkel, A. Shish, Y. Mardor, M. Schnaider Beeri
Primary Reference (PubMED ID):
Funding Source:
Alzheimer's Association
Study Goal and Principal Findings:

Type 2 diabetes (T2D) is associated with increased risk of Alzheimer's disease (AD). There is evidence for impaired blood–brain barrier (BBB) in both diseases, but its role in the interplay between them is not clear. Here, we investigated the effects of high‐fat diet (HFD), a model for T2D, on the Tg2576 mouse model of AD, in regard to BBB function. We showed that HFD mice had higher weight, more insulin resistance, and higher serum HDL cholesterol levels, primarily in Tg2576 mice, which also had higher brain lipids content. In terms of behavior, Tg2576 HFD mice were less active and more anxious, but had better learning in the Morris Water Maze compared to Tg2576 on regular diet. HFD had no effect on the level of amyloid beta 1–42 in the cortex of Tg2576 mice, but increased the transcription level of insulin receptor in the hippocampus. Tg2576 mice on regular diet demonstrated more BBB disruption at 8 and 12 months accompanied by larger lateral ventricles volume in contrast to Tg2576 HFD mice, whose BBB leakage and ventricular volume were similar to wild‐type (WT) mice. Our results suggest that in AD, HFD may promote better cognitive function through improvements of BBB function and of brain atrophy but not of amyloid beta levels. Lipid metabolism in the CNS and peripheral tissues and brain insulin signaling may underlie this protection.

Therapeutic Agent

Therapeutic Information:
Therapy Type:
Dietary Interventions & Supplements
Therapeutic Agent:
High Fat Diet
Therapeutic Target:
Multi Target

Animal Model

Model Information:
Species:
Mouse
Model Type:
APP
Strain/Genetic Background:
C57BL/6J

Experimental Design

Is the following information reported in the study?:
Power/Sample Size Calculation
Randomized into Groups
Blinded for Treatment
Blinded for Outcome Measures
Pharmacokinetic Measures
Pharmacodynamic Measures
Toxicology Measures
ADME Measures
Biomarkers
Dose
Formulation
Route of Delivery
Duration of Treatment
Frequency of Administration
Age of Animal at the Beginning of Treatment
Age of Animal at the End of Treatment
Sex as a Biological Variable
Study Balanced for Sex as a Biological Variable
Number of Premature Deaths
Number of Excluded Animals
Statistical Plan
Genetic Background
Inclusion/Exclusion Criteria Included
Conflict of Interest

Outcomes

Outcome Measured
Outcome Parameters
Behavioral
Exploratory Activity
Morris Water Maze
Open Field Test
Motor Function
Locomotor Activity
Biochemical
Brain-Buffer Soluble beta Amyloid Peptide 42
Brain-Guanidine Soluble beta Amyloid Peptide 42
Blood-Glucose Level
Insulin Tolerance Test
Insulin Receptor mRNA
Brain-Total Cholesterol
Brain-Lipid Profile
Serum-Total Cholesterol
Serum-Lipid Profile
Imaging
MRI-Blood Brain Barrier Integrity
MRI-Vessel Function Map
Magnetic Resonance Imaging (MRI)
Toxicology
Body Weight